Alberto Muñoz Llarena-rekin lankidetzan egindako argitalpenak (8)

2015

  1. Efficacy and safety of fixed-dose-rate infusions of gemcitabine plus erlotinib for advanced pancreatic cancer

    Journal of Analytical Oncology, Vol. 4, Núm. 1, pp. 44-51

2014

  1. Bevacizumab in combination with FOLFIRI in the first-line treatment of patients with advanced colorectal cancer: A single-institution experience

    Journal of Analytical Oncology, Vol. 3, Núm. 1, pp. 26-32

  2. Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 10

2013

  1. Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells

    PLoS ONE, Vol. 8, Núm. 5

2012

  1. Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

    Molecular Cancer, Vol. 11

2006

  1. Metastatic non-small-cell lung carcinoma successfully treated with pre-operative chemotherapy and bilateral adrenalectomy

    Japanese Journal of Clinical Oncology, Vol. 36, Núm. 11, pp. 731-734

2003

  1. Incidencia y mortalidad del cáncer. Historia natural

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 100, Núm. 4, pp. 139-143

2001

  1. Crisis addisoniana como primera manifestación de insuficiencia suprarrenal en paciente diagnosticado de cáncer de pulmón

    Anales de medicina interna, Vol. 18, Núm. 1, pp. 35-37